Abbott
ABT
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 8 hours ago • ABT
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
PRNewsWire • 3 days ago • ABT
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
Zacks Investment Research • 4 days ago • ABT
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research • 6 days ago • ABT
PBH or ABT: Which Is the Better Value Stock Right Now?
The Motley Fool • 7 days ago • ABT
This Top Dividend King Just Became an Even Better Buy
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.